FBXW7 and lung cancer: As shown in Fig. 8A and Additional file 3: Figure S3A, more mutated genes can be detected in arterial CTCs of patients with lung cancer compared with tissues and venous CTCs, and the mutated genes targeted with clinically available drugs (Fbxw7) can only be detected in arterial CTCs.